These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 23502991)

  • 1. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
    Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of patient characteristics on the effectiveness of landiolol in AF/AFL patients complicated with LV dysfunction: Subgroup analysis of the J-Land study.
    Kinugawa K; Nagai R; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
    Adv Ther; 2014 Apr; 31(4):426-39. PubMed ID: 24643403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Effectiveness of Landiolol Between Atrial Fibrillation and Atrial Flutter/Atrial Tachycardia Patients With Left Ventricular Dysfunction.
    Oka E; Iwasaki YK; Maru E; Fujimoto Y; Ito-Hagiwara K; Hayashi H; Yamamoto T; Yodogawa K; Hayashi M; Shimizu W
    Circ J; 2019 Mar; 83(4):793-800. PubMed ID: 30814430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Landiolol and Digoxin as an Intravenous Drug for Controlling the Heart Rate in Patients with Atrial Fibrillation and Severely Depressed Left Ventricular Function.
    Shinohara M; Wada R; Yano K; Akitsu K; Koike H; Kinoshita T; Suzuki T; Fujino T; Ikeda T
    Int Heart J; 2020 Sep; 61(5):944-950. PubMed ID: 32921677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute rate control in atrial fibrillation with left ventricular dysfunction.
    Momomura S
    Circ J; 2013; 77(4):893-4. PubMed ID: 23502988
    [No Abstract]   [Full Text] [Related]  

  • 6. Landiolol: A Review in Tachyarrhythmias.
    Syed YY
    Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
    Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
    J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
    Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
    Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    Yamashita T; Saitoh T; Matsushita M
    J Cardiol; 2015 Jul; 66(1):69-72. PubMed ID: 25454208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-Label Two-Dose Pilot Study of Landiolol for the Treatment of Atrial Fibrillation/Atrial Flutter in Caucasian Patients.
    Stix G; Wolzt M; Domanovits H; Kadlecová P; Husch B; Trebs M; Hodisch J; Unger M; Krumpl G
    Circ J; 2019 Dec; 84(1):33-42. PubMed ID: 31813897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial.
    Sumitomo N; Horigome H; Miura M; Ono H; Ueda H; Takigiku K; Yoshimoto J; Ohashi N; Suzuki T; Sagawa K; Ushinohama H; Takahashi K; Miyazaki A; Sakaguchi H; Iwamoto M; Takamuro M; Tokunaga C; Nagano T;
    J Cardiol; 2017 Sep; 70(3):232-237. PubMed ID: 28073682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure - AF-CHF landiolol survey.
    Yamashita T; Nakasu Y; Mizutani H; Sumitani K
    J Cardiol; 2019 Nov; 74(5):418-425. PubMed ID: 31255463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
    Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
    Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
    Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
    Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel use of the ultra-short-acting intravenous β1-selective blocker landiolol for supraventricular tachyarrhythmias in patients with congestive heart failure.
    Adachi T; Sato A; Baba M; Hiraya D; Hasegawa T; Kuroki K; Hoshi T; Aonuma K
    Heart Vessels; 2014 Jul; 29(4):464-9. PubMed ID: 23801459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of fatal 1:1 conducted atrial flutter to less conducted ratio by landiolol infusion.
    Takata J; Haruyama N; Arashi T; Mae T
    J Anesth; 2016 Aug; 30(4):716-9. PubMed ID: 27085543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction.
    Wada Y; Aiba T; Tsujita Y; Itoh H; Wada M; Nakajima I; Ishibashi K; Okamura H; Miyamoto K; Noda T; Sugano Y; Kanzaki H; Anzai T; Kusano K; Yasuda S; Horie M; Ogawa H
    J Arrhythm; 2016 Apr; 32(2):82-8. PubMed ID: 27092187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of a β1-Blocker to Milrinone Treatment Improves Cardiac Function in Patients with Acute Heart Failure and Rapid Atrial Fibrillation.
    Kobayashi S; Myoren T; Kajii T; Kohno M; Nanno T; Ishiguchi H; Nishimura S; Fukuda M; Hino A; Fujimura T; Ono M; Uchinoumi H; Tateishi H; Mochizuki M; Oda T; Okuda S; Yoshiga Y; Kawano R; Yano M
    Cardiology; 2019; 142(4):195-202. PubMed ID: 31137022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
    Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
    Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.